| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/17/2023 | Edgewise Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 200k | $7.08 | $1.4M | | 08/17/2023 |
| 05/02/2023 | Edgewise Therapeutics, Inc. | | Sale | Common Stock | 3.3k | $8.90 | $29k | | 05/01/2023 |
| 05/01/2023 | Edgewise Therapeutics, Inc. | | Exercise | Restricted Stock Units | 10.4k | $0.00 | $0 | | 05/01/2023 |
| 08/08/2022 | Edgewise Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 240k | $10.39 | $2.5M | | 08/08/2022 |
| 05/01/2022 | Edgewise Therapeutics, Inc. | | Grant | Restricted Stock Units | 31.2k | $0.00 | $0 | | 05/01/2022 |
| 08/17/2021 | Edgewise Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 160k | $16.38 | $2.6M | | 08/17/2021 |
| 04/30/2021 | Edgewise Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 160k | $28.64 | $4.6M | | 04/30/2021 |
| 02/12/2020 | Astria Therapeutics, Inc. | ATXS | Grant | Stock Option (right to buy) | 60k | $5.32 | $319.2k | | 02/12/2020 |
| 02/13/2019 | Astria Therapeutics, Inc. | ATXS | Grant | Stock Option (right to buy) | 40k | $4.39 | $175.6k | | 02/13/2019 |
| 09/07/2018 | Astria Therapeutics, Inc. | ATXS | Grant | Stock Option (right to buy) | 150k | $0.71 | $106.5k | | 09/07/2018 |
| 02/08/2018 | Astria Therapeutics, Inc. | ATXS | Grant | Stock Option (right to buy) | 100k | $1.28 | $128k | | 02/08/2018 |